Cargando…

Defining Models to Classify between Benign and Malignant Adnexal Masses Using Routine Laboratory Parameters

SIMPLE SUMMARY: In patients with adnexal masses, classification into benign or malignant tumors is essential for optimal treatment planning, but remains challenging. In the search for new models applicable in a routine clinical setting, we compared classical single parameters to multiparameter predi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reiser, Elisabeth, Pils, Dietmar, Grimm, Christoph, Hoffmann, Ines, Polterauer, Stephan, Kranawetter, Marlene, Aust, Stefanie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264825/ https://www.ncbi.nlm.nih.gov/pubmed/35804981 http://dx.doi.org/10.3390/cancers14133210

Ejemplares similares

Development of a tool for prediction of ovarian cancer in patients with adnexal masses: Value of plasma fibrinogen
por: Seebacher, Veronika, et al.
Publicado: (2017)

Corrected Allele Frequency of BRCA1/2 Mutations Is an Independent Prognostic Factor for Treatment Response to PARP-Inhibitors in Ovarian Cancer Patients
por: Grech, Christina T., et al.
Publicado: (2022)

The prognostic value of estrogen receptor beta and proline-, glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer
por: Aust, Stefanie, et al.
Publicado: (2013)

NECTIN4 (PVRL4) as Putative Therapeutic Target for a Specific Subtype of High Grade Serous Ovarian Cancer—An Integrative Multi-Omics Approach
por: Bekos, Christine, et al.
Publicado: (2019)

Skeletal Muscle Depletion and Markers for Cancer Cachexia Are Strong Prognostic Factors in Epithelial Ovarian Cancer
por: Aust, Stefanie, et al.
Publicado: (2015)

Conservative Management of Asymptomatic Adnexal Masses Classified as Benign by the IOTA ADNEX Model: A Prospective Multicenter Portuguese Study
por: Brito, Marta Espanhol, et al.
Publicado: (2021)

PD-1 and PD-L1 expression on TILs in peritoneal metastases compared to ovarian tumor tissues and its associations with clinical outcome
por: Bekos, Christine, et al.
Publicado: (2021)

Precision Medicine Tumor Boards: Clinical Applicability of Personalized Treatment Concepts in Ovarian Cancer
por: Aust, Stefanie, et al.
Publicado: (2020)

Small RNAs and the competing endogenous RNA network in high grade serous ovarian cancer tumor spread
por: Bachmayr-Heyda, Anna, et al.
Publicado: (2016)

Reliability of Tumor Testing Compared to Germline Testing for Detecting BRCA1 and BRCA2 Mutations in Patients with Epithelial Ovarian Cancer
por: Bekos, Christine, et al.
Publicado: (2021)

Increased genitourinary fistula rate after bevacizumab in recurrent cervical cancer patients initially treated with definitive radiochemotherapy and image-guided adaptive brachytherapy
por: Sturdza, Alina, et al.
Publicado: (2017)

A Global Gene Body Methylation Measure Correlates Independently with Overall Survival in Solid Cancer Types
por: Pils, Dietmar, et al.
Publicado: (2020)

Adnexal Masses Suspected to Be Benign Treated with Laparoscopy
por: Demir, Richard H., et al.
Publicado: (2012)

Practical Recommendations for the Management of Benign Adnexal Masses
por: Rocha, Rodrigo Manieri, et al.
Publicado: (2020)

Evaluation of Probably Benign Adnexal Masses in Postmenopausal Women
por: Karakaya, Burcu Kisa, et al.
Publicado: (2017)

Factors associated with post-relapse survival in patients with recurrent cervical cancer: the value of the inflammation-based Glasgow Prognostic Score
por: Seebacher, Veronika, et al.
Publicado: (2018)

Ovarian Adnexal Reporting Data System (O-RADS) for Classifying Adnexal Masses: A Systematic Review and Meta-Analysis
por: Vara, Julio, et al.
Publicado: (2022)

Surgical outcomes of adnexal masses classified by IOTA ultrasound simple rules
por: Carballo, Erica V., et al.
Publicado: (2022)

Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients - a study of the OVCAD consortium
por: Bachmayr-Heyda, Anna, et al.
Publicado: (2013)

Peritoneal tumor spread in serous ovarian cancer-epithelial mesenchymal status and outcome
por: Auer, Katharina, et al.
Publicado: (2015)

Benign vs. Malignant Skin Adnexal Neoplasms: How Useful are Silhouettes?
por: Tirumalae, Rajalakshmi, et al.
Publicado: (2013)

Microcystic adnexal carcinoma of the upper lip misdiagnosed benign desmoplastic trichoepithelioma
por: Rustemeyer, Jan, et al.
Publicado: (2012)

Mini-Laparoscopic Versus Conventional Laparoscopic Surgery for Benign Adnexal Masses
por: Gencdal, Servet, et al.
Publicado: (2017)

Comparison of Ultrasound Scores in Differentiating between Benign and Malignant Adnexal Masses
por: Pelayo, Mar, et al.
Publicado: (2023)

Absence of PD-L1 on tumor cells is associated with reduced MHC I expression and PD-L1 expression increases in recurrent serous ovarian cancer
por: Aust, Stefanie, et al.
Publicado: (2017)

The value of pretreatment serum butyrylcholinesterase level as a novel prognostic biomarker in patients with cervical cancer treated with primary (chemo-)radiation therapy
por: Poetsch, Nina, et al.
Publicado: (2019)

Two different, mutually exclusively distributed, TP53 mutations in ovarian and peritoneal tumor tissues of a serous ovarian cancer patient: indicative for tumor origin?
por: Sukhbaatar, Nyamdelger, et al.
Publicado: (2017)

Differences in perioperative outcomes after laparoscopic management of benign and malignant adnexal masses
por: Gad, Mohamad S., et al.
Publicado: (2011)

Evaluation of the Diagnostic Value of the Ultrasound ADNEX Model for Benign and Malignant Ovarian Tumors
por: Peng, Xiao-Shan, et al.
Publicado: (2021)

Ultrasound Features and Ultrasound Scores in the Differentiation between Benign and Malignant Adnexal Masses
por: Pelayo, Mar, et al.
Publicado: (2023)

Role of the immune system in the peritoneal tumor spread of high grade serous ovarian cancer
por: Auer, Katharina, et al.
Publicado: (2016)

Risk Reclassification of Patients with Endometrial Cancer Based on Tumor Molecular Profiling: First Real World Data
por: Oberndorfer, Felicitas, et al.
Publicado: (2021)

Biomarker-Based Models for Preoperative Assessment of Adnexal Mass: A Multicenter Validation Study
por: Watrowski, Rafał, et al.
Publicado: (2022)

The systemic immune-inflammation index (SII) is an independent prognostic parameter of survival in patients with invasive vulvar cancer
por: Bartl, Thomas, et al.
Publicado: (2020)

Molecular Guided Treatments in Gynecologic Oncology: Analysis of a Real‐World Precision Cancer Medicine Platform
por: Taghizadeh, Hossein, et al.
Publicado: (2020)

Laparoendoscopic Single-Site Surgery for the Treatment of Benign Adnexal Disease: A Prospective Trial
por: Fagotti, Anna, et al.
Publicado: (2010)

GATA3 Expression in Normal Skin and in Benign and Malignant Epidermal and Cutaneous Adnexal Neoplasms
por: Mertens, Richard B., et al.
Publicado: (2015)

Quantitative global lipidomics analysis of patients with ovarian cancer versus benign adnexal mass
por: Buas, Matthew F., et al.
Publicado: (2021)

Impact of frailty on the management of patients with gynecological cancer aged 80 years and older
por: Reiser, Elisabeth, et al.
Publicado: (2020)

Benign Vulvar Adnexal Tumours - A 5 year Study in a Tertiary Care Hospital
por: Tiwana, Kanwardeep Kaur, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_beqj7h00k2u4dp5kjb1nsie6ia